Type IIA Secretory Phospholipase A2 Up-Regulates Cyclooxygenase-2 and Amplifies Cytokine-Mediated Prostaglandin Production in Human Rheumatoid Synoviocytes1

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Immunology

• Publication date

  2000-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.165.5.2790PMID 10946311
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis.

  2000influential reference
• Structures, Enzymatic Properties, and Expression of Novel Human and Mouse Secretory Phospholipase A2s*

  2000cited by this paper
• Novel Human Secreted Phospholipase A2 with Homology to the Group III Bee Venom Enzyme*

  2000cited by this paper
• Cloning and Recombinant Expression of a Novel Mouse-secreted Phospholipase A2 *

  1999cited by this paper
• Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation.

  1999cited by this paper
• p38 Mitogen-activated Protein Kinase Regulates Cyclooxygenase-2 mRNA Stability and Transcription in Lipopolysaccharide-treated Human Monocytes*

  1999cited by this paper
• Functional coupling and differential regulation of the Phospholipase A2‐cyclooxygenase pathways in inflammation

  1999cited by this paper
• On the diversity of secreted phospholipases A(2). Cloning, tissue distribution, and functional expression of two novel mouse group II enzymes.

  1999cited by this paper
• Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target.

  1999cited by this paper
• Overexpression of Cyclooxygenase-2 Induces Cell Cycle Arrest

  1999cited by this paper
• COX-2 inhibitors.

  1999cited by this paper
• COX-2 inhibitors.

  1999cited by this paper
• Regulation of type V phospholipase A2 expression and function by proinflammatory stimuli.

  1999cited by this paper
• Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases.

  1998cited by this paper
• Prostaglandin E 2 , Interleukin 1 a , and Tumor Necrosis Factor- a Increase Human Osteoclast Formation and Bone Resorption in Vitro *

  1998cited by this paper
• Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases.

  1998cited by this paper
• Induction of cyclooxygenase-2 by secretory phospholipases A2 in nerve growth factor-stimulated rat serosal mast cells is facilitated by interaction with fibroblasts and mediated by a mechanism independent of their enzymatic functions.

  1998cited by this paper
• NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint.

  1998cited by this paper
• Increased expression of human type IIa secretory phospholipase A2 antigen in arthritic synovium

  1998cited by this paper
• New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study.

  1998cited by this paper
• Joint inflammation and cartilage destruction may occur uncoupled.

  1998cited by this paper
• Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro.

  1998cited by this paper
• Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics.

  1997cited by this paper
• Role of Cytosolic PLA2, Secretory PLA2 and Nitric Oxide Synthase in Inflammation

  1997cited by this paper
• Prostaglandin E2 Amplifies Cytosolic Phospholipase A2- and Cyclooxygenase-2-dependent Delayed Prostaglandin E2 Generation in Mouse Osteoblastic Cells

  1997cited by this paper
• Studies on the contribution of c-fos/AP-1 to arthritic joint destruction.

  1997cited by this paper
• Cyclooxygenase-2-dependent delayed prostaglandin D2 generation is initiated by nerve growth factor in rat peritoneal mast cells: its augmentation by extracellular type II secretory phospholipase A2.

  1997cited by this paper
• The Role of Cytokines in Rheumatoid Arthritis

  1996cited by this paper
• Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes.

  1996cited by this paper
• Role of cytokines in rheumatoid arthritis.

  1996cited by this paper
• Native Peptide Inhibition

  1996cited by this paper
• Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo

  1996cited by this paper
• Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis.

  1996cited by this paper
• Native Peptide Inhibition SPECIFIC INHIBITION OF TYPE II PHOSPHOLIPASES A 2 BY SYNTHETIC PEPTIDES DERIVED FROM THE PRIMARY SEQUENCE*

  1996cited by this paper
• Manipulation of distinct NFkappaB proteins alters interleukin-1beta-induced human rheumatoid synovial fibroblast prostaglandin E2 formation.

  1996cited by this paper
• Low-molecular-weight, calcium-dependent phospholipase A2 genes are linked and map to homologous chromosome regions in mouse and human.

  1996cited by this paper
• Secretory phospholipase A2 as an index of disease activity in rheumatoid arthritis. Prospective double blind study of 212 patients.

  1996cited by this paper
• Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate.

  1996cited by this paper
• TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.

  1996cited by this paper
• Manipulation of Distinct NFκB Proteins Alters Interleukin-1β-induced Human Rheumatoid Synovial Fibroblast Prostaglandin E2 Formation*

  1996cited by this paper
• Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2

  1995cited by this paper
• Interleukin-1 beta induces cytosolic phospholipase A2 and prostaglandin H synthase in rheumatoid synovial fibroblasts. Evidence for their roles in the production of prostaglandin E2.

  1994cited by this paper
• NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro.

  1994influential reference
• Interleukin‐1β induces cytosolic phospholipase a2 and prostaglandin h synthase in rheumatoid synovial fibroblasts

  1994cited by this paper
• Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.

  1994cited by this paper
• Enzymatic activity and immunoreactivity of extracellular phospholipase A2 in inflammatory synovial fluids

  1992cited by this paper
• Measurement of human phospholipase A2 in arthritis plasma using a newly developed sandwich ELISA.

  1992cited by this paper
• Human extracellular recombinant phospholipase A2 induces an inflammatory response in rabbit joints.

  1991cited by this paper
• Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

  1991cited by this paper
• Circulating phospholipase A2 activity associated with sepsis and septic shock is indistinguishable from that associated with rheumatoid arthritis

  1991cited by this paper
• Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid.

  1989cited by this paper

• Targeting secreted PLA2 interactions with EGFR and vimentin to arrest prostate tumour growth

  2025cites this paper
• sPLA2-IIA inhibitor Tricyclic Dipyrido Diazepinone derivative 6 f suppresses poultry organic dust-induced pulmonary inflammation by downregulating ERK1/2-cPLA2 pathway.

  2025cites this paper
• Targeted Metabolomic Analysis of Serum Free Fatty Acids: Lipidomics Disturbance in Patients with Superior Limbic Keratoconjunctivitis.

  2024cites this paper
• Cartilage oligomeric matrix protein as a potential biomarker for knee osteoarthritis

  2024cites this paper
• Cellular Distribution of Secreted Phospholipase A2 in Lungs of IPF Patients and Its Inhibition in Bleomycin-Induced Pulmonary Fibrosis in Mice

  2023cites this paper
• Sinapicacid Inhibits Group IIA Secretory Phospholipase A2 and Its Inflammatory Response in Mice

  2022cites this paper
• Group IIA secreted phospholipase A2 inhibition by elemolic acid as a function of anti-inflammatory activity

  2022cites this paper
• Human Group IIA Phospholipase A2—Three Decades on from Its Discovery

  2021cites this paper
• Integrated Pathways of COX-2 and mTOR: Roles in Cell Sensing and Alzheimer’s Disease

  2020cites this paper
• sPLA2-IIa participates in ocular surface inflammation in humans with dry eye disease.

  2020cites this paper
• Clusterin Is Associated with Systemic and Synovial Inflammation in Knee Osteoarthritis

  2020cites this paper
• Interleukin-34 overexpression mediated through tumor necrosis factor-alpha reflects severity of synovitis in knee osteoarthritis

  2020cites this paper
• Structural and Functional Aspects of Targeting the Secreted Human Group IIA Phospholipase A2

  2020influential citation
• Secretory Phospholipase A2 Inhibition Attenuates Adhesive Properties of Esophageal Barrett's Cells.

  2020cites this paper
• Respective contribution of cytosolic phospholipase A2α and secreted phospholipase A2 IIA to inflammation and eicosanoid production in arthritis.

  2019cites this paper
• Roles of secreted phospholipase A2 group IIA in inflammation and host defense.

  2019cites this paper
• Metabolomics Profiling before, during, and after the Beijing Olympics: A Panel Study of Within-Individual Differences during Periods of High and Low Air Pollution

  2019cites this paper
• The need for Group IIA secretory phospholipase A2 (sPLA2-IIA) inhibitors in inflammatory ocular disease treatment

  2018cites this paper
• Maslinic acid modulates secreted phospholipase A2-IIA (sPLA2-IIA)-mediated inflammatory effects in macrophage foam cells formation

  2018cites this paper
• Activation of Notch-1 in oral epithelial cells by P. gingivalis triggers the expression of the antimicrobial protein PLA2-IIA

  2018cites this paper
• Key Genotypes and the Response to Nutrient Supplementation in Crohn’s Disease

  2018cites this paper
• The role of group IIA secretory phospholipase A2 (sPLA2-IIA) as a biomarker for the diagnosis of sepsis and bacterial infection in adults—A systematic review

  2017cites this paper
• Inhibition of Human Group IIA-Secreted Phospholipase A2 and THP-1 Monocyte Recruitment by Maslinic Acid

  2016cites this paper
• Secreted phospholipase A2 is increased in meconium-stained amniotic fluid of term gestations: potential implications for the genesis of meconium aspiration syndrome

  2014cites this paper
• Clinical and Biochemical Tear Lipid Parameters in Contact Lens Wearers

  2014cites this paper
• and Inhibition of Its Secretion by the Lethal Phospholipase A2 against Bacillus anthracis High Bactericidal Efficiency of Type IIA

  2013cites this paper
• Management of Hyperuricemia and Gout

  2013cites this paper
• Selective Inhibition of Human Group IIA-secreted Phospholipase A 2 ( hGIIA ) Signaling Reveals Arachidonic Acid Metabolism Is Associated with Colocalization of hGIIA to Vimentin in Rheumatoid

  2013influential citation
• [Functional state of the ileum, cationic peptids and zinc content in the Paneth cells of the rats following lincomycin, indomethacin and methotrexate andministration].

  2013cites this paper
• Phospholipases of Mineralization Competent Cells and Matrix Vesicles: Roles in Physiological and Pathological Mineralizations

  2013cites this paper
• Purification and characterization of a phospholipase A2-IIA from common stingray (Dasyatis pastinaca) intestine.

  2013cites this paper
• A catalytically-inactive snake venom Lys49 phospholipase A₂ homolog induces expression of cyclooxygenase-2 and production of prostaglandins through selected signaling pathways in macrophages.

  2013cites this paper
• Selective Inhibition of Human Group IIA-secreted Phospholipase A2 (hGIIA) Signaling Reveals Arachidonic Acid Metabolism Is Associated with Colocalization of hGIIA to Vimentin in Rheumatoid Synoviocytes*

  2013influential citation
• [Functional state of the ileum, cationic peptids and zinc content in the Paneth cells of the rats following lincomycin, indomethacin and methotrexate andministration].

  2013cites this paper
• Microsoft Word-JBC_Submisison_Revised_Text.docx

  2012influential citation
• PLA 2 G 2 A ( phospholipase A 2 , group IIA ( platelets , synovial fluid ) )

  2012cites this paper
• Absence of inflammatory conditions in human varicose saphenous veins

  2012cites this paper
• Involvement of 15‐lipoxygenase in the inflammatory arthritis

  2012cites this paper
• Phospholipase A2 purification and characterization: a case study.

  2012cites this paper
• Intestinal antimicrobial peptides during homeostasis, infection, and disease

  2012cites this paper
• Secreted phospholipase A(2) group IIA is a neurotoxin released by stimulated human glial cells.

  2012cites this paper
• Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulium toxin B-induced murine dry eye model

  2012cites this paper
• sPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB/c mouse model.

  2011cites this paper
• Cyclic mechanical stretch downregulates IL-1β-induced COX-2 expression and PGE2 production in rheumatoid arthritis fibroblast-like synoviocytes

  2011cites this paper
• Purification and biochemical characterization of a secreted group IIA chicken intestinal phospholipase A2

  2011cites this paper
• Characterizing the role of secretory phospholipase A₂ group IIA in glial cell-mediated neurotoxicity

  2011cites this paper
• PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid))

  2011cites this paper
• Cytosolic phospholipase A2 induction and prostaglandin E2 release by interleukin-1β via the myeloid differentiation factor 88-dependent pathway and cooperation of p300, Akt, and NF-κB activity in human rheumatoid arthritis synovial fibroblasts.

  2011cites this paper
• A phospholipase A₂ from Bothrops asper snake venom activates neutrophils in culture: expression of cyclooxygenase-2 and PGE₂ biosynthesis.

  2011cites this paper
• Modulation of growth in human esophageal adenocarcinoma cells by group IIa secretory phospholipase A(2).

  2010cites this paper
• cPLA2 is protective against COX inhibitor-induced intestinal damage.

  2010cites this paper
• Gastroduodenal reflux induces group IIa secretory phospholipase A(2) expression and activity in murine esophagus.

  2010cites this paper
• A Bifunctional Role for Group IIA Secreted Phospholipase A2 in Human Rheumatoid Fibroblast-like Synoviocyte Arachidonic Acid Metabolism*

  2010cites this paper
• Secreted phospholipases A(2): A proinflammatory connection between macrophages and mast cells in the human lung.

  2009cites this paper
• The use of live-animal micro-computed tomography to determine the effect of a novel phospholipase A2 inhibitor on alveolar bone loss in an in vivo mouse model of periodontitis.

  2009cites this paper
• Expression of cyclooxygenase-1 and -2 in IL-1beta-induced synovitis of the temporomandibular joint.

  2009cites this paper
• Suppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1β-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg mice

  2009cites this paper
• sPLA2-IIa is an inflammatory mediator when the ocular surface is compromised.

  2009influential citation
• Rôle de la phospholipase A2 de type V dans le recrutement de leucocytes au foyer inflammatoire

  2009cites this paper
• Increased type IIA secretory phospholipase A2 expression contributes to oxidative stress in end-stage renal disease

  2009cites this paper
• Collagen-Mediated Rheumatoid Arthritis Novel Role of Pin1 Induction in Type II

  2009cites this paper
• Novel Role of Pin 1 Induction in Type II Collagen-Mediated Rheumatoid Arthritis 1

  2009cites this paper
• Novel Role of Pin1 Induction in Type II Collagen-Mediated Rheumatoid Arthritis1

  2009cites this paper
• leucocytes au foyer inflammatoire

  2008cites this paper
• Secretory phospholipases A(2) isolated from Bothrops asper and from Crotalus durissus terrificus snake venoms induce distinct mechanisms for biosynthesis of prostaglandins E2 and D2 and expression of cyclooxygenases.

  2008cites this paper
• The roles of sPLA2-IIA (Pla2g2a) in cancer of the small and large intestine.

  2008cites this paper
• The roles of sPLA 2-IIA ( Pla 2 g 2 a ) in cancer of the small and large intestine

  2008cites this paper
• Detection of Parvovirus B19 Nucleic Acids and Expression of Viral VP1/VP2 Antigen in Human Colon Carcinoma

  2007cites this paper
• Implication of cytosolic phospholipase A2 (cPLA2) in the regulation of human synoviocyte NADPH oxidase (Nox2) activity.

  2007cites this paper
• This information is current as Biosynthetic Pathway 2 Prostaglandin E Evidence for Divergent Influence on the Expression in Human Orbital Fibroblasts : Prostaglandin Endoperoxide H Synthase 2 of β Jak 2 Dampens the Induction by IL-1

  2007cites this paper
• Jak2 Dampens the Induction by IL-1β of Prostaglandin Endoperoxide H Synthase 2 Expression in Human Orbital Fibroblasts: Evidence for Divergent Influence on the Prostaglandin E2 Biosynthetic Pathway1

  2007cites this paper
• Novel peptide inhibitors of human secretory phospholipase A2 with antiinflammatory activity: solution structure and molecular modeling.

  2007cites this paper
• Recombinant production and properties of binding of the full set of mouse secreted phospholipases A2 to the mouse M-type receptor.

  2007cites this paper
• This information is current as Biosynthetic Pathway 2 Prostaglandin E Evidence for Divergent Influence on the Expression in Human Orbital Fibroblasts : Prostaglandin Endoperoxide H Synthase 2 of β Jak 2 Dampens the Induction by IL-1

  2007cites this paper
• Immunomodulatory Drug CC-4047 is a Cell-type and Stimulus-Selective Transcriptional Inhibitor of Cyclooxygenase 2

  2007cites this paper
• Selective induction of cyclooxygenase‐2 plays a role in lysophosphatidic acid regulated Fas ligand cell surface presentation

  2006cites this paper
• Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein.

  2006cites this paper
• Antifibrotic Activity of an Inhibitor of Group IIA Secretory Phospholipase A2 in Young Spontaneously Hypertensive Rats

  2006cites this paper
• Marine sponge metabolites for the control of inflammatory diseases.

  2006cites this paper
• Spontaneously Hypertensive Rats in Young 2 IIA Secretory Phospholipase A Antifibrotic Activity of an Inhibitor of Group

  2006cites this paper
• Activation of human inflammatory cells by secreted phospholipases A2.

  2006cites this paper
• Secreted phospholipase A2 inhibitors are also potent blockers of binding to the M-type receptor.

  2006influential citation
• Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?

  2006cites this paper
• Inhibitors of cyclo-oxygenase-2 and secretory phospholipase A2 preserve bone architecture following ovariectomy in adult rats.

  2006cites this paper
• Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders.

  2006cites this paper
• Paneth cells: leukocyte‐like mediators of innate immunity in the intestine

  2006cites this paper
• S-2474, a novel nonsteroidal anti-inflammatory drug, rescues cortical neurons from human group IIA secretory phospholipase A(2)-induced apoptosis.

  2005cites this paper
• Original Research Papers Overlapping gene expression profiles in rheumatoid fibroblast-like synoviocytes induced by the proinflammatory cytokines interleukin-1b and tumor necrosis factor

  2005cites this paper
• In Vivo Protective Role of Human Group IIA Phospholipase A2 against Experimental Anthrax1

  2005cites this paper
• A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis.

  2005cites this paper
• Inflammatory events induced by Lys-49 and Asp-49 phospholipases A2 isolated from Bothrops asper snake venom: role of catalytic activity.

  2005cites this paper
• Various secretory phospholipase A2 enzymes are expressed in rheumatoid arthritis and augment prostaglandin production in cultured synovial cells

  2005cites this paper
• Increase of cyclooxygenase-2 expression by interleukin 15 in rheumatoid synoviocytes.

  2004cites this paper
• Overlapping gene expression profiles in rheumatoid fibroblast-like synoviocytes induced by the proinflammatory cytokines interleukin-1 β and tumor necrosis factor

  2004cites this paper
• Group IB Secretory Phospholipase A2 Stimulates CXC Chemokine Ligand 8 Production via ERK and NF-κB in Human Neutrophils1

  2004cites this paper
• Effect of phospholipase A2 inhibitory peptide on inflammatory arthritis in a TNF transgenic mouse model: a time-course ultrastructural study

  2004cites this paper
• High Bactericidal Efficiency of Type IIA Phospholipase A2 against Bacillus anthracis and Inhibition of Its Secretion by the Lethal Toxin1

  2004cites this paper
• Elevated secretory non-pancreatic type II phospholipase A2 serum activity is associated with impaired endothelial vasodilator function in patients with coronary artery disease.

  2004cites this paper
• Cytosolic phospholipase A2alpha reigns supreme in arthritis and bone resorption.

  2004cites this paper
• Cytosolic phospholipase A2α reigns supreme in arthritis and bone resorption

  2004cites this paper